Clinical trial
Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
NCT02488954 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
- Lead sponsor
- Rennes University Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 12, 2016
- Completion date
- June 30, 2017
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis